Cowboys and cowgirls came together for the 13th Annual Lost N Lava Cowboy Gathering on Friday afternoon. The public was welcomed with several arts and craft booths along with food vendors and of ...
LAVA Therapeutics N.V. (LVTX) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.27 per share a year ...
LAVA Therapeutics N.V. (LVTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (LVTX) today ...
EMERYVILLE, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation ("XOMA Royalty”) (Nasdaq: XOMA) today announced it has successfully completed its previously announced acquisition of all ...
LAVA Therapeutics N.V. is a biopharmaceutical company that has developed several clinical-stage bispecific gamma delta T cell engagers using its proprietary Gammabody® platform, including JNJ-89853413 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback